AlphaGrep UK
GMED icon

AlphaGrep UK’s Globus Medical GMED Stock Holding History

AlphaGrep UK’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.47M Buy
19,587
+15,186
+345% +$1.2M 0.44% 5
2026
Q2 		$348K Buy
+4,401
New +$374K 0.1% 392
2026
Q1 		– Sell
-2,330
Closed -$203K – 842
2025
Q4 		$203K Buy
+2,330
New +$177K 0.07% 620

Other funds holding GMED

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $26.8B AUM 3.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

AlphaGrep UK's GMED Position: Q3 2026 in Review

AlphaGrep UK increased its Globus Medical (GMED) stake by 345% in Q3 2026, buying an estimated $1.2M and bringing the position to 19,587 shares worth $1.47M. The position accounts for 0.44% of the portfolio, ranked #5.

AlphaGrep UK first reported a position in GMED in Q4 2025 and has held it in 3 quarters since. 512 funds tracked by Wall St. Rank hold GMED as of Q3 2026.

  • AlphaGrep UK held 19,587 shares of Globus Medical worth $1.47M as of Q3 2026.
  • AlphaGrep UK bought 15,186 Globus Medical shares in Q3 2026, an estimated $1.2M.
  • Globus Medical made up 0.44% of AlphaGrep UK's portfolio in Q3 2026, its #5 holding.
  • AlphaGrep UK first reported a position in Globus Medical in Q4 2025 and has held it in 3 quarters since.
  • 512 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.